Health-related quality of life and associated factors in patients undergoing kidney replacement therapies.

IF 1 Q4 PHARMACOLOGY & PHARMACY FARMACIA HOSPITALARIA Pub Date : 2024-12-09 DOI:10.1016/j.farma.2024.11.002
Alfonso Pereira-Céspedes, Alberto Jiménez-Morales, Aurora Polo-Moyano, Elizabeth Spruce-Esparza, Magdalena Palomares-Bayo, Fernando Martínez-Martínez, Miguel Ángel Calleja-Hernández
{"title":"Health-related quality of life and associated factors in patients undergoing kidney replacement therapies.","authors":"Alfonso Pereira-Céspedes, Alberto Jiménez-Morales, Aurora Polo-Moyano, Elizabeth Spruce-Esparza, Magdalena Palomares-Bayo, Fernando Martínez-Martínez, Miguel Ángel Calleja-Hernández","doi":"10.1016/j.farma.2024.11.002","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Characterize the health-related quality of life among patients undergoing kidney replacement therapy and to explore associated factors.</p><p><strong>Method: </strong>A descriptive observational study was conducted using the Kidney Disease Quality of Life Short Form (KDQOL-SF) questionnaire to assess health-related quality of life. The Dader Method was employed to evaluate negative outcomes associated with medications. Face-to-face interviews and clinical records were utilized to collect sociodemographic and clinical data from patients undergoing kidney replacement therapy at the Nephrology Department of Virgen de las Nieves University Hospital (Granada, Spain). We explored the association between independent variables (clinical and demographic factors) and dependent variables (Mental Component Score and Physical Component Score) using the lineal regression method.</p><p><strong>Results: </strong>Ninety-one participants were included, 47 (48.35%) were females. The mean age was 62 years, 52 patients (57.14%) were on hemodialysis, 13 patients (14.29%) on peritoneal dialysis, and 26 patients (28.57%) on other forms of kidney replacement therapy. The study revealed a mean Physical Component Score of 40.89 and a Mental Component Score of 47.19. Additionally, 98.90% of the patients experienced negative outcomes associated with medications. Influential factors include age, comorbid conditions, the number of medications, and clinical parameters such as vitamin D and calcium levels.</p><p><strong>Conclusions: </strong>This study underscores significant findings in patients undergoing kidney replacement therapy, indicating low Mental Component Score and Physical Component Score, accompanied by negative outcomes associated with medications.</p>","PeriodicalId":45860,"journal":{"name":"FARMACIA HOSPITALARIA","volume":" ","pages":""},"PeriodicalIF":1.0000,"publicationDate":"2024-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"FARMACIA HOSPITALARIA","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.farma.2024.11.002","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Characterize the health-related quality of life among patients undergoing kidney replacement therapy and to explore associated factors.

Method: A descriptive observational study was conducted using the Kidney Disease Quality of Life Short Form (KDQOL-SF) questionnaire to assess health-related quality of life. The Dader Method was employed to evaluate negative outcomes associated with medications. Face-to-face interviews and clinical records were utilized to collect sociodemographic and clinical data from patients undergoing kidney replacement therapy at the Nephrology Department of Virgen de las Nieves University Hospital (Granada, Spain). We explored the association between independent variables (clinical and demographic factors) and dependent variables (Mental Component Score and Physical Component Score) using the lineal regression method.

Results: Ninety-one participants were included, 47 (48.35%) were females. The mean age was 62 years, 52 patients (57.14%) were on hemodialysis, 13 patients (14.29%) on peritoneal dialysis, and 26 patients (28.57%) on other forms of kidney replacement therapy. The study revealed a mean Physical Component Score of 40.89 and a Mental Component Score of 47.19. Additionally, 98.90% of the patients experienced negative outcomes associated with medications. Influential factors include age, comorbid conditions, the number of medications, and clinical parameters such as vitamin D and calcium levels.

Conclusions: This study underscores significant findings in patients undergoing kidney replacement therapy, indicating low Mental Component Score and Physical Component Score, accompanied by negative outcomes associated with medications.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
接受肾脏替代疗法患者的健康相关生活质量及相关因素
目的:探讨肾替代治疗患者健康相关生活质量的特征,并探讨相关因素。方法:采用肾脏疾病生活质量短表(KDQOL-SF)问卷进行描述性观察研究,评估与健康相关的生活质量。Dader法用于评估与药物相关的负面结果。通过面对面访谈和临床记录,收集了在西班牙格拉纳达的维根德拉斯尼夫斯大学医院肾内科接受肾脏替代治疗的患者的社会人口统计学和临床数据。我们使用线性回归方法探讨了自变量(临床和人口统计学因素)与因变量(心理成分得分和身体成分得分)之间的关系。结果:共纳入91例受试者,其中女性47例,占48.35%。平均年龄62 岁,血液透析52例(57.14%),腹膜透析13例(14.29%),其他肾脏替代治疗26例(28.57%)。研究显示,平均身体成分得分为40.89分,精神成分得分为47.19分。此外,98.90%的患者经历了与药物相关的负面结果。影响因素包括年龄、合并症、药物数量和临床参数,如维生素D和钙水平。结论:本研究强调了接受肾脏替代治疗的患者的重要发现,表明精神成分评分和身体成分评分较低,并伴有与药物相关的负面结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
FARMACIA HOSPITALARIA
FARMACIA HOSPITALARIA PHARMACOLOGY & PHARMACY-
CiteScore
1.90
自引率
21.40%
发文量
46
审稿时长
37 days
期刊介绍: Una gran revista para acceder a los mejores artículos originales y revisiones de la farmacoterapia actual. Además, es Órgano de expresión científica de la Sociedad Española de Farmacia Hospitalaria, y está indexada en Index Medicus/Medline, EMBASE/Excerpta Médica, Alert, Internacional Pharmaceutical Abstracts y SCOPUS.
期刊最新文献
Stability of thermolabile drugs at room temperature. A review. Criteria for medication reconciliation in major orthopedic surgery in high-risk patients: A consensus based on the Delphi method. Messenger RNA as a new strategy against cancer. Effectiveness and safety of liposomal rapamycin for the treatment of facial angiofibromas in tuberous sclerosis. [Translated article] Pharmacokinetic-guided switching from standard half-life factor VIII to extended half-life pegylated factor VIII in haemophilia A therapy in clinical practice.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1